Literature DB >> 12639203

Echinacea and truth in labeling.

Christine M Gilroy1, John F Steiner, Tim Byers, Howard Shapiro, William Georgian.   

Abstract

BACKGROUND: Echinacea sales represent 10% of the dietary supplement market in the United States, but there is no guarantee as to the content, quality, variability, or contamination in Echinacea preparations.
OBJECTIVE: To qualitatively and quantitatively assess the contents of Echinacea-only preparations available in a retail setting.
METHODS: One of each single-herb Echinacea preparations that were available in August 2000 was obtained from several stores in the Denver, Colo, area. Thin-layer chromatography (TLC) was used to determine species and measure quantity. From this information, accuracy of species labeling and comparison of constituent to labeled content were assessed. The samples were stratified by whether they were labeled as standardized, and the standardized and nonstandardized samples were compared by ratio of constituent to labeled content.
RESULTS: Of the samples, 6 (10%) of 59 preparations contained no measurable Echinacea. The assayed species content was consistent with labeled content in 31 (52%) of the samples. Of the 21 standardized preparations, 9 (43%) met the quality standard described on the label. Labeled milligrams were weakly associated with measured constituent (r = 0.35; P =.02).
CONCLUSIONS: Echinacea from retail stores often does not contain the labeled species. A claim of "standardization" does not mean the preparation is accurately labeled, nor does it indicate less variability in concentration of constituents of the herb.

Entities:  

Mesh:

Year:  2003        PMID: 12639203     DOI: 10.1001/archinte.163.6.699

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  16 in total

1.  Determination of major phenolic compounds in Echinacea spp. raw materials and finished products by high-performance liquid chromatography with ultraviolet detection: single-laboratory validation matrix extension.

Authors:  Paula N Brown; Michael Chan; Lori Paley; Joseph M Betz
Journal:  J AOAC Int       Date:  2011 Sep-Oct       Impact factor: 1.913

2.  Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients.

Authors:  José Moltó; Marta Valle; Cristina Miranda; Samandhy Cedeño; Eugenia Negredo; Manuel José Barbanoj; Bonaventura Clotet
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

Review 3.  Review of the regulations for clinical research in herbal medicines in USA.

Authors:  Tony Yuqi Tang; Fang-Zhou Li; Janyne Afseth
Journal:  Chin J Integr Med       Date:  2014-11-27       Impact factor: 1.978

4.  Pharmacokinetic enhancers (cobicistat/ritonavir) and the potential for drug-drug interactions.

Authors:  Paul Hollywood; Rachel MacCann; David Lorigan; Eoghan de Barra; Samuel McConkey
Journal:  Ir J Med Sci       Date:  2019-11-18       Impact factor: 1.568

Review 5.  Echinacea for preventing and treating the common cold.

Authors:  Marlies Karsch-Völk; Bruce Barrett; David Kiefer; Rudolf Bauer; Karin Ardjomand-Woelkart; Klaus Linde
Journal:  Cochrane Database Syst Rev       Date:  2014-02-20

6.  Echinacea tennesseensis ethanol tinctures harbor cytokine- and proliferation-enhancing capacities.

Authors:  David S Senchina; Dustin A McCann; Gina N Flinn; Lankun Wu; Zili Zhai; Joan E Cunnick; Eve S Wurtele; Marian L Kohut
Journal:  Cytokine       Date:  2009-03-14       Impact factor: 3.861

7.  Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.

Authors:  Bill J Gurley; Ashley Swain; Martha A Hubbard; D Keith Williams; Gary Barone; Faith Hartsfield; Yudong Tong; Danielle J Carrier; Shreekar Cheboyina; Sunil K Battu
Journal:  Mol Nutr Food Res       Date:  2008-07       Impact factor: 5.914

8.  Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics.

Authors:  Bill J Gurley; Ashley Swain; D Keith Williams; Gary Barone; Sunil K Battu
Journal:  Mol Nutr Food Res       Date:  2008-07       Impact factor: 5.914

9.  Herb-drug interaction between Echinacea purpurea and etravirine in HIV-infected patients.

Authors:  José Moltó; Marta Valle; Cristina Miranda; Samandhy Cedeño; Eugenia Negredo; Bonaventura Clotet
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

Review 10.  Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases.

Authors:  James B Hudson
Journal:  J Biomed Biotechnol       Date:  2011-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.